Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 4012 Marsico Hall, 125 Mason Farm Road, Chapel Hill, North Carolina, 27599, USA.
Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
AAPS J. 2022 Jan 7;24(1):24. doi: 10.1208/s12248-021-00676-9.
Influenza affects millions of people worldwide and can result in severe sickness and even death. The best method of prevention is vaccination; however, the seasonal influenza vaccine often suffers from low efficacy and requires yearly vaccination due to changes in strain and viral mutations. More conserved universal influenza antigens like M2 ectodomain (M2e) and the stalk region of hemagglutinin (HA stalk) have been used clinically but often suffer from low antigenicity. To increase antigenicity, universal antigens have been formulated using nano/microparticles as vaccine carriers against influenza. Utilizing polymers, liposomes, metal, and protein-based particles, indicators of immunity and protection in mouse, pig, ferrets, and chicken models of influenza have been shown. In this review, seasonal and universal influenza vaccine formulations comprised of these materials including their physiochemical properties, fabrication, characterization, and biologic responses in vivo are highlighted. The review is concluded with future perspectives for nano/microparticles as carrier systems and other considerations within the universal influenza vaccine delivery landscape. Graphical Abstract.
流感影响着全球数百万人,可导致严重疾病甚至死亡。预防的最佳方法是接种疫苗;然而,由于流感株的变化和病毒突变,季节性流感疫苗的效果往往不佳,需要每年接种。像 M2 胞外域 (M2e) 和血凝素茎部 (HA 茎) 这样更保守的通用流感抗原已在临床上使用,但通常抗原性较低。为了提高抗原性,已经使用纳米/微粒作为流感疫苗载体来制备通用抗原。利用聚合物、脂质体、金属和基于蛋白质的颗粒,已经在流感的小鼠、猪、雪貂和鸡模型中显示出了免疫和保护的指标。在这篇综述中,重点介绍了由这些材料组成的季节性和通用流感疫苗配方,包括它们的物理化学性质、制备、表征和体内的生物学反应。最后,对纳米/微粒作为载体系统的未来展望以及通用流感疫苗传递领域的其他考虑因素进行了总结。